IHH Healthcare unveils bold new brand identity
August 29, 2025
(First from right) Dr Prem Kumar Nair, Group CEO of IHH Healthcare, with Dilip Kadambi, Group Chief Financial Officer, and Ashok Pandit, Group Chief Corporate Officer, addressing questions from the media during the press conference.
IHH Healthcare ("IHH" or "the Group") unveiled its new brand identity, marking a significant milestone in its multiyear transformation journey. Initiated in 2024, this transformation aims to make healthcare future-ready by aligning IHH’s multinational presence under a single vision. The rebrand seeks to foster greater clarity, cohesion, and synergy across IHH’s global network.
The Group brings together over 70,000 staff across a wide portfolio of trusted healthcare brands, including Acibadem, Gleneagles, Fortis, Island, Mount Elizabeth, Pantai, Parkway, and Prince Court. With the launch, these entities now share a unified aspiration: Care For Good. A new chapter beyond the logo For Dr Prem Kumar Nair, Group CEO of IHH Healthcare, the rebrand represents more than a visual refresh. “Since the company was formed and listed in 2012, there was just one logo. We felt it was time for change. This goes beyond colours or symbols—it is about what we want to become: a healthcare leader catalyzing positive change across the ecosystem.” Insights from the Future Health.Now forum The rebrand was announced alongside the Future Health.Now forum, which convened over 300 leaders from healthcare, government, and business sectors. Participants from China, Hong Kong, Singapore, Malaysia, and India exchanged insights on four transformative themes:
Partnerships as a defining feature of IHH Dr Prem emphasized that IHH aims to move beyond routine investor relations into catalyzing system-wide change. “We want to spark new ideas, create partnerships, and elevate healthcare systems. These collaborations will define our path forward.” Across IHH’s 140 facilities in 10 markets, including over 80 tertiary hospitals, the Group sees itself as responsible for shaping the future of healthcare. Its approach combines accessibility, sustainability, and raising clinical standards while centering patient experience. Seven pillars of transformation IHH’s holistic transformation strategy spans seven focus areas:
The meaning behind the new logo Janet Low, Vice President of Communications and Branding at IHH, explained the new single-colour logo. The blue hue conveys trust and steadfastness, while a hint of purple signifies innovation. “The curve symbolizes patients’ seamless care journey and collaborative partnerships. It reflects our promise to elevate patient care through innovation, partnerships, and value-driven approaches.” The simplified design unifies IHH’s diverse brands under a coherent identity while signaling a future-ready organization. Strengthening public-private partnerships In Malaysia, IHH has actively partnered with the government through its Life Renewed Programmes, offering radiotherapy and related services. These collaborations alleviate public hospital pressures by shifting patients who can access private services. “Private healthcare helps take the load off overstretched public systems,” said Dr Prem. Other initiatives include resource sharing, joint surgeries with public hospitals, and preventive healthcare through private GPs. These measures aim to balance public demand with private sector support, ensuring equitable care. Affordable and accessible care through innovation IHH leverages AI-driven value-based care models to optimize treatment costs across markets. By comparing data on procedures, outcomes, and consumption patterns, IHH refines care pathways to ensure affordability without compromising quality. Additionally, bulk procurement across its 10-country network lowers costs of medical supplies and advanced equipment such as MRIs, CT scanners, and PET-CTs. “Patients ultimately benefit when we negotiate the best prices for medical technologies,” Dr Prem noted. Malaysia’s role in IHH’s growth Singapore remains IHH’s largest revenue contributor, followed by Turkey and Eastern Europe. Malaysia is the Group’s third-largest market, contributing about 70% to overall revenue. With its ageing population and robust demand for healthcare, Malaysia remains a key growth driver. Malaysian healthcare is both high-quality and cost-effective, positioning the country as a growing medical travel hub. Travellers from Singapore and beyond increasingly seek care in Malaysia, complementing the nation’s strong domestic demand. Expanding ambulatory and primary care Ashok Pandit, Group Chief Corporate Officer, highlighted the Group’s focus on ambulatory care centres. “We’ve launched in Singapore and Hong Kong and plan to expand in Malaysia. Smaller facilities reduce patient costs while delivering end-to-end services.” Beyond hospitals, IHH is building ecosystems spanning labs, primary care, ambulatory centres, and tertiary hospitals. Digitalization and seamless data systems are central to this integration. Rethinking cancer care delivery Dr Prem illustrated the shift towards outpatient care with cancer treatment. “Chemotherapy patients should not endure hospital parking struggles and long corridors for routine treatments. Ambulatory chemotherapy centres closer to patients’ homes provide a more humane, sustainable approach.” This vision reflects IHH’s belief that hospital-heavy systems are unsustainable. Future care must expand into outpatient and community-based models. Preparing for the future of care Looking ahead, IHH sees opportunities in:
As healthcare evolves, IHH’s transformation emphasizes sustainable growth, equitable access, and resilient systems to meet rising global challenges. |
|
EXPLORE FURTHER
|
Illumina and ScienceVision selected as sequencing technology partners for MyGenom projectMyGenom project to sequence 10,000 Malaysian genomes
|
|
Pantai Hospital (KL) introduces Outpatient Parenteral Antimicrobial Therapy (OPAT)Outpatient IV antimicrobial therapy eliminates need for extended hospitalization
|
|
Maaedicare fundraiser ball delivers RM500,000 boost for kidney, cardiac patientsSupporting free dialysis, heart health services, and free healthcare at 'Klinik Amal Percuma' for 256 patients
|
|
National Heart Institute (IJN) introduces Evolut FX device to treat aortic stenosisAddressing the needs of patients with small aortic annulus
|
|
Learn to save lives: Join our basic life support (BLS) courseDamai Pain Care & Wellness, in collaboration with Universiti Malaysia Sabah, offers BLS course led by AHA-certified instructors
|
|
Duopharma Biotech explores collaboration in halal pharmaceuticals at Doha roundtablePromising potential highlighted for bilateral relations between Malaysia - Qatar
|
|
Regency Specialist Hospital enters Malaysian Book of Records with diabetes screening campaign3,148 participants screened within three days
|
|
Sunway Medical Centre launches CSR radiotherapy program for cancer in SarawakSarawak ranks as the state with the 5th highest cancer incidence rates
|
|
EncoreMed shines brights at APHM conference, redefining healthcare with unified hospital digital solutionReducing hospital congestion by 50%
|
|
DKSH offers support to shelter home for children50 volunteers dedicate their efforts to create a comfortable environment
|
|
New ERT Nexviazyme approved for treatment of Pompe diseaseImproving lung function, walking distance, and muscle strength
|
|
Aurelius Healthcare and Rizman Ruzaini enhance staff uniforms across departments13 carefully crafted sets for easy identification
|
|
Taking quality lumbar support to new heightsWorld's first cordless massage chair debuts on the peak of Mount Kinabalu
|
|
DKSH Malaysia - Botrem partner to revolutionize skin rehabilitationTargeted solutions for persistent allergies
|
|
Duopharma Biotech - Owen Mumford partners to distribute medical devicesDiabetes and eye care products to be distributed as part of the agreement
|
|
Columbia Asia sets foot in Bukit JalilSeven-story hospital offering 96 ward beds and multi-specialties
|
|
Sunway Medical Centre Velocity introduces robotic surgery serviceA minimally invasive alternative to laparoscopic surgery
|
|
Danone Malaysia - the first food company to be certified B CorporationAdvocate of Iron Deficiency Anaemia (IDA) among Malaysian children
|
|
Preserving female cancer patients' fertility via cryopreservationIdeal for girls pre-puberty and women in reproductive age
|
|
Monurol (Fosfomycin Trometamol) receives DCA approval for transrectal prostate biopsy in adult menNew indication of perioperative antibiotic prophylaxis
|
|
Roche-MUIS announce funding for breast cancer patientsAccess to neoadjuvant therapy for HER-2 positive breast cancer patients
|
|
5-year-old Khaivan gains hearing ability through cochlear implant surgeryAudiolab's hearing solutions bring hope to those with hearing loss
|
|
Mahkota Medical Centre earns CCPC accreditation for breast cancerRM250 million investment towards healthcare transformation
|
|
UMW Toyota's generous donation bolsters cancer society's vital servicesExpanding cancer care reach and access
|
